» Articles » PMID: 33235108

Correlation Between LncRNA SNHG16 Gene Polymorphism and Its Interaction with Environmental Factors and Susceptibility to Colorectal Cancer

Overview
Specialty General Medicine
Date 2020 Nov 25
PMID 33235108
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To study the relationship between long-chain non-coding RNA small nucleolar RNA host gene 16 (lncRNA SNHG16) polymorphisms and its interaction with environmental factors and susceptibility to colorectal cancer (CRC).

Methods: Sanger sequencing was used to analyze genotypes of lncRNA SNHG16 gene rs7353, rs8038, and rs15278 sites. Multifactor dimensionality reduction was used to analyze interactions between lncRNA SNHG16 gene rs7353, rs8038, rs15278 sites, and environmental factors. Haploview 4.1 software was used to analyze linkage disequilibrium of lncRNA SNHG16 gene rs7353, rs8038, and rs15278 sites. Quantitative real-time polymerase chain reaction was used to analyze plasma lncRNA SNHG16 levels of CRC patients and control subjects.

Results: Variation of the lncRNA SNHG16 gene rs7353 site A>G variation was associated with decreased CRC susceptibility (Odds ratio [OR] = 0.50, 95% confidence interval [CI]: 0.40-0.62, P < .01). The rs8038 site G>A and rs15278 site A>G variation were associated with increased CRC susceptibility (OR = 1.87, 95% CI: 1.47-2.36, P < .01). The rs15278 site G>A variation was associated with increased CRC susceptibility (OR = 2.24, 95% CI: 1.61-3.11, P < .01). Interaction combinations featuring age, rs7353, rs8038, and rs15278 single nucleotide polymorphism are 13.53 times more susceptible to CRC than other interactions (95% CI: 9.43-19.41, P < .01). The rs15278, rs8038, and rs7353 site AGA haplotypes were significantly associated with a decreased CRC risk (OR = 0.65, 95% CI: 0.48-0.88, P = .01), AAG haplotypes were significantly associated with an increased CRC risk (OR = 2.00, 95% CI: 1.27-3.17, P < .01). High lncRNA SNHG16 expression was associated with tumor progression in CRC patients (χ = 8.85, P = .03). The rs7353 site A>G variation caused a significant decrease in plasma lncRNA SNHG16 level (P < .01), while the rs8038 site G>A variation and rs15278 site A>G variation resulted in increased plasma lncRNA SNHG16 levels.

Conclusion: Polymorphisms of lncRNA SNHG16 gene rs7353, rs8038, rs15278 loci and their interaction with age are significantly associated with CRC susceptibility.

Citing Articles

Molecular mechanisms underlying roles of long non-coding RNA small nucleolar RNA host gene 16 in digestive system cancers.

Yang T, Li X, Kong M World J Gastrointest Oncol. 2024; 16(11):4300-4308.

PMID: 39554746 PMC: 11551640. DOI: 10.4251/wjgo.v16.i11.4300.


Roles of long non‑coding RNA SNHG16 in human digestive system cancer (Review).

Zhao L, Kan Y, Wang L, Pan J, Li Y, Zhu H Oncol Rep. 2024; 52(2).

PMID: 38940337 PMC: 11234248. DOI: 10.3892/or.2024.8765.


The Intergenic Type LncRNA (LINC RNA) Faces in Cancer with In Silico Scope and a Directed Lens to LINC00511: A Step toward ncRNA Precision.

Eldash S, Sanad E, Nada D, Hamdy N Noncoding RNA. 2023; 9(5).

PMID: 37888204 PMC: 10610215. DOI: 10.3390/ncrna9050058.


The Role of Sex-specific Long Non-coding RNAs in Cancer Prevention and Therapy.

Song H, Kim S J Cancer Prev. 2021; 26(2):98-109.

PMID: 34258248 PMC: 8249206. DOI: 10.15430/JCP.2021.26.2.98.

References
1.
Jedi M, Young G, Pedersen S, Symonds E . Methylation and Gene Expression of and in Colorectal Cancer Tissues. Clin Med Insights Oncol. 2018; 12:1179554918775064. PMC: 5952276. DOI: 10.1177/1179554918775064. View

2.
Duan W, Du L, Jiang X, Wang R, Yan S, Xie Y . Identification of a serum circulating lncRNA panel for the diagnosis and recurrence prediction of bladder cancer. Oncotarget. 2016; 7(48):78850-78858. PMC: 5346682. DOI: 10.18632/oncotarget.12880. View

3.
Singh S, Ghosh S . Polymorphisms of XRCC1 and XRCC2 DNA Repair genes and Interaction with Environmental Factors Influence the Risk of Nasopharyngeal Carcinoma in Northeast India. Asian Pac J Cancer Prev. 2016; 17(6):2811-9. View

4.
Amirkhah R, Farazmand A, Irfan-Maqsood M, Wolkenhauer O, Schmitz U . The role of microRNAs in the resistance to colorectal cancer treatments. Cell Mol Biol (Noisy-le-grand). 2015; 61(6):17-23. View

5.
Deng B, Wang B, Fang J, Zhu X, Cao Z, Lin Q . MiRNA-203 suppresses cell proliferation, migration and invasion in colorectal cancer via targeting of EIF5A2. Sci Rep. 2016; 6:28301. PMC: 4931903. DOI: 10.1038/srep28301. View